Global Platelet Rich Plasma Market: Trends Defining Future Performance

The global platelet rich plasma (PRP) market is witnessing immense growth on account of a rapid rise in demand for therapies utilizing PRP. Awareness regarding the benefits of PRP therapy is attracting a larger consumer base.

According to a report published by Transparency Market Research, the global platelet rich plasma market had reached a value of US$16 million in 2013. Expanding at a healthy CAGR of 11.9% during the period of 2014-2020, this market is poised to reach around US$35 million by the end of the forecast period.

Browse The Market Research Report of Platelet Rich Plasma Market: 

http://www.transparencymarketresearch.com/platelet-rich-plasma-market.html

Let’s take a look at what is trending in the global platelet rich plasma market:

• The P-PRP market emerged as the leading segment among all the PRP products in the market in 2013. This market occupied more than 60% of the overall market that year. P-PRP is the traditional type of platelet rich plasma, which is the main reason behind the growth of this market segment.

• In the coming years, the L-PRP market is projected to post the fastest growth on account of the huge number of leukocytes and stem cells that speed up the healing process of injuries.

• Among applications, orthopedic surgery dominated the global market in 2013, holding around 30% of the market. The prevalence of orthopedic and sports injuries, coupled with the global rise in geriatric population, is the major cause that has led to the growth of this market, as PRP therapy is highly efficient in the treatment of orthopedic injuries.

• Currently, the market for cosmetic surgeries is also witnessing extensive growth on account of the various applications of PRP in cosmetic surgeries. The cost-efficiency of PRP therapies is another factor drawing the interest of customers toward the treatment, significantly fueling the market.

• Autologus PRP was the biggest segment of the global PRP market based on its origin in 2013. However, the market is losing ground to PRP products and therapies of allogenic origin. The allogenic PRP market is likely to report the highest growth rate in the near future. The lesser time taken by allogenic PRP to heal a wound is the key reason why people are getting more interested in it.

• North America is the traditional market for PRP on account of the presence of a large base of major players in the region. The region occupied over 50% of the global market in 2013. The rising number of orthopedic and cosmetic surgeries and increasing awareness regarding PRP products and therapies in North America is helping the market register strong business.

• In recent times, the PRP market in Asia Pacific has showed huge potential and emerged as a lucrative industry. Owing to the robust development, the market is poised to witness the fastest growth in the coming years. The rapid rise in medical tourism, ample availability of domestic players, presence of a large base of geriatric population, and the increasing awareness pertaining to PRP therapies is expected to push the Asia Pacific PRP market.

Browse The Press Release of Platelet Rich Plasma Market: 

http://www.transparencymarketresearch.com/pressrelease/platelet-rich-plasma-market.htm

The global PRP market is led by Biomet, Harvest Technologies, Arteriocyte Medical Systems Inc., and Arthrex Inc. Innovating effective PRP products together with a broad distribution network is the key to success in this market.